Complexo Hospital de Clínicas da Universidade Federal do Paraná, Universidade Federal do Paraná, Curitiba, PR, Brasil.
Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brasil.
Braz J Med Biol Res. 2021 Feb 26;54(4):e10022. doi: 10.1590/1414-431X202010022. eCollection 2021.
Chronic kidney disease (CKD) is one of the main chronic diseases affecting the world population due to its high prevalence and increasing morbidity. Similarly, obesity gained the interest of the scientific community as it directly or indirectly increases mortality from cardiovascular causes, and its prevalence characterizes a pandemic. The objective of this study was to investigate obesity measured by body mass index as a predictor for end-stage renal disease in the general adult population. A systematic review and meta-analysis was carried out by searching 10 databases for prospective or retrospective cohort studies, with no restrictions on the language of publication, including adults with obesity without previous renal disease and who evolved to CKD (diagnosed by estimated glomerular filtration rate below 60 mL&mac_middot;min-1&mac_middot;(1.73 m2)-1 over the follow-up period. The R software and Meta package were used for data analysis. After removing duplicates, 5431 studies were submitted to the steps of the systematic review, and 21 articles were included in the data analysis. In total, 3,504,303 patients, 521,216 with obesity, and an average follow-up time of 9.86 years were included. The relative risk of obese people for developing CKD in the random effects model was 1.81 (95%CI: 1.52-2.16). The evidence found in this meta-analysis confirmed that obese people are at higher risk of developing CKD that the non-obese population (1.81 times higher), with obesity being a priority risk factor in preventive actions.
慢性肾脏病(CKD)是影响世界人口的主要慢性疾病之一,其患病率高,发病率不断上升。同样,肥胖也引起了科学界的关注,因为它直接或间接增加了心血管原因导致的死亡率,而且其患病率具有大流行的特征。本研究旨在探讨肥胖症(以体重指数衡量)作为普通成年人群终末期肾病的预测因子。通过搜索 10 个数据库,进行了系统评价和荟萃分析,纳入了前瞻性或回顾性队列研究,对发表语言没有限制,包括无先前肾脏疾病的肥胖成年人,且在随访期间进展为 CKD(通过估算肾小球滤过率低于 60 mL·min-1·(1.73 m2)-1 诊断)。使用 R 软件和 Meta 包进行数据分析。在去除重复项后,5431 项研究被提交给系统评价的步骤,21 项研究被纳入数据分析。共纳入 3504303 名患者,521216 名肥胖患者,平均随访时间为 9.86 年。在随机效应模型中,肥胖者发生 CKD 的相对风险为 1.81(95%CI:1.52-2.16)。荟萃分析中的证据证实,肥胖者发生 CKD 的风险高于非肥胖者(高 1.81 倍),肥胖是预防措施中的优先风险因素。